25 May 2013
Keywords: UK, NICE, PharmaMr, Zeltia, Yondelis, GlaxoSmithKline, Arzerra
Article | 20 September 2010
The UK’s National Institute for Health and Clinical Excellence (NICE) gave another couple of negative opinions for use ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 September 2010
24 May 2013
© 2013 thepharmaletter.com